agilon health (AGL) 2024 Wells Fargo Healthcare Conference summary

Cost trends and financial performance

• Cost trend expectations for Q1 were reduced from over 10% to 8.2%, with Q2 at 7.3% and Q3 forecasted at 6%, reflecting improved cost management.

• Inpatient medical costs remain elevated but are tracking in line with expectations, with Q2 inpatient admissions lower than Q1.

• Retroactive contract termination and new membership growth impacted PMPM yields, with risk adjustment data also contributing to lower revenue guidance.

• Cash use for 2023 is projected at $125–$150 million, with $408 million on the balance sheet and a significant reduction in cash burn expected in 2024.

• Enhanced data visibility and a new financial data pipeline are being implemented to improve real-time cost tracking and business management.

Membership growth and cohort performance

• The 2024 cohort is the largest to date, with strong partners and successful early implementation.

• The 2025 class includes five groups and 60,000 senior patients, mostly in existing states, reflecting a prudent growth strategy.

• Same store growth is expected to be at or above local market rates, with physician engagement initiatives driving improved performance.

• Active panel reviews and local medical director involvement have led to an 8% reduction in ER and inpatient utilization in early markets.

• Hospital partnerships are expanding, with three health system partners performing well and integration efforts ongoing.

Contracting, payer dynamics, and future outlook

• 50% of membership bids for 2025 have been received, with the remainder expected soon; analysis is ongoing to inform next year’s strategy.

• Part D changes under the Inflation Reduction Act are prompting active negotiations to carve out or corridor benefits, with positive payer receptivity.

• 40% of contracts are up for renewal for 2025, with all contracts to be repriced by 2027, including new language to reduce volatility.

• Supplemental benefit carve-outs are being discussed, with openness from payers to adjust benefit structures.

• Value-based care penetration is a priority for payers, with the company delivering 200–300 basis points better performance than fee-for-service alternatives.